Brainstorm Cell Therapeutics Inc. (BCLI) vs Curanex Pharmaceuticals Inc (CURX)

Brainstorm Cell Therapeutics Inc. and Curanex Pharmaceuticals Inc are both Biotechnology companies. Brainstorm Cell Therapeutics Inc. and Curanex Pharmaceuticals Inc are of similar size ($7.0M and $7.0M). Across the 9 metrics below, Brainstorm Cell Therapeutics Inc. leads on 7 and Curanex Pharmaceuticals Inc on 2.

Valuation

Metric BCLI CURX Biotechnology median
P/E n/m n/m 7.88
P/S n/m n/m 11.47
P/B n/m 1.40 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales n/m n/m 10.73
Earnings yield (97.01%) (164.56%) (28.84%)
Free cash flow yield (38.35%) (179.68%) (23.03%)

Profitability

Metric BCLI CURX Biotechnology median
Gross margin 0.00% — 65.16%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 119.20% (411.10%) (57.72%)
Return on assets (627.43%) (357.22%) (49.22%)
Return on invested capital 0.00% (356.67%) 0.00%

Growth

Metric BCLI CURX Biotechnology median
Revenue growth (TTM) — — 5.64%
EPS growth (last fiscal year) 51.95% (466.67%) —
Revenue growth, 5-year CAGR — — 8.40%
Net income growth, 5-year CAGR 0.00% — 0.00%

Health

Metric BCLI CURX Biotechnology median
Debt to equity (0.11) 0.00 0.00
Current ratio 0.03 45.95 4.73
Net debt to EBITDA (0.10) 1.20 0.96

Dividend

Metric BCLI CURX Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 — 0.00

Size

Metric BCLI CURX Biotechnology median
Market cap 6.99m 6.98m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack